173 related articles for article (PubMed ID: 8675656)
21. A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin.
Binnie CG; Lord ST
Thromb Haemost; 1991 Feb; 65(2):165-8. PubMed ID: 2053103
[TBL] [Abstract][Full Text] [Related]
22. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
[TBL] [Abstract][Full Text] [Related]
23. A survey of furin substrate specificity using substrate phage display.
Matthews DJ; Goodman LJ; Gorman CM; Wells JA
Protein Sci; 1994 Aug; 3(8):1197-205. PubMed ID: 7987214
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
Loreth RM; Meyer M; Albert FW
Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
[TBL] [Abstract][Full Text] [Related]
25. A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing.
Wada Y; Niwa K; Maekawa H; Asakura S; Sugo T; Nakanishi M; Auerswald G; Popp M; Matsuda M
Thromb Haemost; 1993 Sep; 70(3):397-403. PubMed ID: 8259537
[TBL] [Abstract][Full Text] [Related]
26. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin.
Morsy J; Garten W; Rott R
Virology; 1994 Aug; 202(2):988-91. PubMed ID: 8030261
[TBL] [Abstract][Full Text] [Related]
27. 'Pergularain e I'--a plant cysteine protease with thrombin-like activity from Pergularia extensa latex.
Shivaprasad HV; Rajaiah R; Frey BM; Frey FJ; Vishwanath BS
Thromb Res; 2010 Mar; 125(3):e100-5. PubMed ID: 19853890
[TBL] [Abstract][Full Text] [Related]
28. Maturation of secreted meprin alpha during biosynthesis: role of the furin site and identification of the COOH-terminal amino acids of the mouse kidney metalloprotease subunit.
Tang J; Bond JS
Arch Biochem Biophys; 1998 Jan; 349(1):192-200. PubMed ID: 9439598
[TBL] [Abstract][Full Text] [Related]
29. Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.
Brennan SO; Davis RL; Conard K; Savo A; Furuya KN
Liver Int; 2010 Nov; 30(10):1541-7. PubMed ID: 20666993
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
31. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
32. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
[TBL] [Abstract][Full Text] [Related]
33. Thrombin hydrolysis of an N-terminal peptide from fibrinogen Lille: kinetic and NMR studies.
Zheng Z; Ashton RW; Ni F; Scheraga HA
Biochemistry; 1992 May; 31(18):4426-31. PubMed ID: 1581297
[TBL] [Abstract][Full Text] [Related]
34. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
35. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
[TBL] [Abstract][Full Text] [Related]
36. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
37. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
Brennan SO; Wyatt JM; May S; De Caigney S; George PM
Thromb Haemost; 2001 Mar; 85(3):450-3. PubMed ID: 11307813
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
39. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
